Summer Promo: $39/mo $85 with code SUMMER26 · See pricing →Limited Time Only

Alternatives

Top 5 Evaluate Alternatives for Life Sciences Teams (2026)

Evaluate (EvaluatePharma) is the industry standard for consensus forecasts and valuation. But forecasting, R&D research, and commercial selling are different jobs. Here are the best alternatives, compared honestly.

Book a demo Try interactive demo

4.8 rating on G2

By Semir JahicCEO & Co-Founder, SalesmotionLast reviewed June 2026

At a glance

How Evaluate Alternatives Compare

Side-by-side comparison of the key capabilities that matter most.

Feature	Salesmotion	Clarivate	Citeline	GlobalData	IQVIA
Primary Strength	Commercial sponsor discovery, signals & outreach	Curated R&D, pipeline & regulatory data	Pipeline & clinical-trial intelligence	Broad pharma market & R&D intelligence	Commercial analytics & real-world evidence
Best For	BD & sales teams selling into sponsors	R&D, regulatory & competitive intelligence	Trial planning & competitive intelligence	Market research & strategy teams	Enterprise commercial analytics at scale
Forecasting / Valuation	Not a forecasting tool	Some commercial analytics	Pipeline data, not consensus forecasts	Market sizing & forecasting	Deep commercial forecasting & RWE
Decision-Maker Contacts	Verified contacts (email + phone)	No	No (investigators/sites only)	No	Limited (HCP data, enterprise)
AI Outreach	AI drafts anchored to the trigger	No	No	No (AI sales collateral only)	No
Pricing	$85/mo for individuals. Custom pricing for teams & enterprise.	Six figures annually (custom)	Custom, enterprise-only	Custom, demo-gated	Enterprise (typically the most expensive)
Rating (G2)	4.8/5	—	—	4.5/5	—

Why teams explore Evaluate alternatives

Evaluate, now part of Norstella, has been a fixture of pharma commercial intelligence since 1996. EvaluatePharma is widely regarded as the definitive source of consensus drug-sales forecasts, with 1.5M+ forecasts dating back to 2003, and Evaluate Omnium adds ML-driven risk/return modeling. For forecasting, valuation, and market analysis, it is trusted by pharma, biotech, banks, and consultancies alike.

Teams look for alternatives for two reasons. Some want a different or broader angle on R&D and market intelligence — which points to Clarivate, Citeline, GlobalData, or IQVIA. Others realize Evaluate isn't built for the job they actually need done: it is a forecasting and analytics platform, with no contact data, no outreach, and no CRM integration. It informs strategy; it doesn't drive a selling motion.

If your goal is to turn sponsor activity into pipeline — finding which sponsors to pursue, knowing when a buying window opens, reaching decision-makers, and sending outreach — you need account intelligence built for commercial teams, not a consensus-forecast database. This guide covers both the research alternatives and the commercial option.

Why Trust This Guide?

I'm Semir Jahic, CEO of Salesmotion. Before founding an account intelligence platform, I spent years in enterprise sales at Salesforce and led revenue teams at Clari. We work with life-sciences commercial teams, including Cytel. This guide is deliberately honest: Salesmotion does not replace a forecasting platform like Evaluate, and I'll say so plainly. The point is to help you match the tool to the job — forecasting, R&D research, or commercial selling — based on real capabilities and public sources, not vendor marketing.

Semir Jahic — CEO & Co-Founder, Salesmotion

Detailed Breakdown

Best Evaluate Alternatives

An in-depth look at each platform, including features, pricing, and limitations.

Salesmotion

Our Pick

G2: 4.8/5

Salesmotion for Life Sciences is an AI-native sponsor-intelligence platform for the commercial side of life sciences. It continuously discovers and classifies sponsors from clinical trials, filings, funding, and the open web, ranks them by fit to what you sell, and surfaces real-time buying signals — then adds verified decision-maker contacts with email and phone and one-click AI outreach.

It is not a forecasting or valuation tool like Evaluate. It solves the commercial problem Evaluate doesn't touch: finding and winning sponsor business.

Best for:BD, sales, and commercial teams (CROs, CDMOs, labs, vendors) that need to find sponsors to sell to and reach the right people

Key Features

Continuous AI discovery of sponsors, ranked by fit to what you sell
Real-time buying signals: first-in-human, phase transitions, readouts, funding
Verified decision-maker contacts with email and phone
AI-drafted outreach anchored to the real trigger
Native Salesforce and HubSpot sync; full API access
Live in days, no enterprise implementation project

Limitations

Not a forecasting or valuation platform — does not replicate EvaluatePharma
No consensus forecasts or probability-of-success modeling
Best for commercial teams, not strategy or finance analysts

Pricing: $85/mo for individuals — flexible monthly billing. Custom pricing for teams and enterprise on request.

4.8 rating on G2 Book a demo

Clarivate (Cortellis)

Visit site

Clarivate's Cortellis suite provides deep, curated R&D intelligence — drug pipeline, clinical trials, regulatory, and deals data across global jurisdictions — with some commercial analytics layered on. For teams that want analytical depth beyond forecasting, it is a strong alternative.

Like Evaluate, it is a research and analytics platform: no decision-maker contacts and no outreach.

Best for:R&D, regulatory, and competitive-strategy teams needing curated pipeline and regulatory data

Key Features

Cortellis drug pipeline and regulatory intelligence
Clinical trial intelligence across global registries
Deals, patents, and drug-discovery databases
Regulatory coverage across 80+ jurisdictions

Limitations

No commercial decision-maker contacts or outreach
Enterprise pricing and onboarding
Built for R&D, not sales prospecting

Pricing: Enterprise contracts, typically six figures annually. Custom by module and seats.

Citeline

Visit site

Citeline (Pharmaprojects, Trialtrove, Sitetrove) is gold-standard pipeline and clinical-trial intelligence, and — like Evaluate — a Norstella company. It is the strongest alternative for teams whose real need is curated R&D and trial data rather than forecasting.

It is a research tool: limited commercial sales data, no decision-maker contacts, no outreach.

Best for:Trial planning, competitive intelligence, and BD&L teams needing curated pipeline and trial data

Key Features

Pharmaprojects — 40+ year global drug-pipeline database
Trialtrove — clinical-trial intelligence from 60,000+ sources
Sitetrove — 570,000+ investigators and 199,000+ sites
AI research tooling and analyst access

Limitations

Limited commercial sales data; no contacts or outreach
No native CRM connector (data API only)
Enterprise pricing, expensive for smaller firms

Pricing: Custom, enterprise-only pricing — no public price.

GlobalData

G2: 4.5/5Visit site

GlobalData's Pharma Intelligence Center offers broad single-platform coverage — pipeline, trials, deals, regulatory, pricing/HTA, epidemiology, and market forecasting — with analyst commentary. It's a capable, often more affordable alternative for market and forecasting research.

It is a research database: no contact data, no outreach engine, and no native CRM integration.

Best for:Market research, forecasting, and strategy teams wanting broad coverage and analyst commentary

Key Features

350+ proprietary databases across drugs, trials, deals, and regulatory data
Epidemiology and disease-market forecasting
Pricing, HTA, and reimbursement intelligence
Ava AI research analyst

Limitations

No contact data, outreach, or native CRM integration
Desktop-first experience some find unwieldy
Less historical depth than legacy databases in some areas

Pricing: Custom, demo-gated pricing — no public price.

IQVIA

Visit site

IQVIA is the enterprise giant of healthcare and pharma commercial intelligence — prescription and claims data, real-world evidence, and large-scale commercial analytics and forecasting. For teams that need the deepest commercial datasets and have the budget, it is the most comprehensive alternative.

It is an analytics and data powerhouse, not a lightweight commercial-prospecting and outreach tool, and it is typically the most expensive and complex option.

Best for:Enterprise commercial analytics, market forecasting, and real-world-evidence programs at scale

Key Features

Prescription and claims data at scale
Real-world evidence and outcomes analytics
Commercial forecasting and market measurement
Global coverage and consulting services

Limitations

Cost and complexity are high; long implementations
Not a lightweight prospecting-to-outreach workflow
Oriented to analytics, not day-to-day BD execution

Pricing: Enterprise pricing — typically the most expensive in the category; custom quotes.

Customer Story

How Cytel cut research time by 50% and consolidated 5 tools into one

50%

less research time

5 → 1

tool consolidation

30%

faster account planning

“All of the vendors that I've worked with, all of the onboarding that I have had to deal with, I will say, hands down, Salesmotion was the easiest that I have had.”

Lyndsay Thomson

Head of Sales Operations, Cytel

Read the full case study

Founder's Take

“Evaluate is the gold standard for consensus forecasts, and if your job is valuation or market sizing, keep it. But Evaluate answers 'what is this market or asset worth?' — not 'which sponsors do I sell to, who do I call, and what do I send?' Most teams asking about Evaluate alternatives are really asking one of two things: do I want a different angle on forecasting and R&D data (Clarivate, GlobalData, IQVIA), or do I actually need a commercial selling tool? If it's the latter, a forecasting database will never get you there — that's a different category.”

Semir Jahic

CEO & Co-Founder, Salesmotion

Summary

Key Takeaways

1Evaluate (a Norstella company) is the industry standard for consensus drug-sales forecasts and valuation — built for strategy, corporate-development, and finance teams, not for selling.
2It provides no decision-maker contacts, no outreach, and no documented CRM integration, and its consensus forecasts can lag real-time events.
3Clarivate (Cortellis) and Citeline are the strongest alternatives for curated R&D and pipeline intelligence; GlobalData adds broad market coverage; IQVIA leads on enterprise commercial analytics and real-world evidence.
4Each of those, like Evaluate, is a research/analytics platform — none is built for commercial prospecting and outreach.
5Salesmotion is the alternative for the commercial motion specifically — sponsor discovery, real-time buying signals, verified contacts with phone, and AI outreach, starting at $85/month.

An honest take

Where Salesmotion isn't the right fit

We'd rather you pick the right tool than the wrong one. Salesmotion isn't for everyone — here's when another option on this page is the smarter call.

You need a built-in email sequencer or dialer. Salesmotion is account intelligence, not a sending tool — it's built to sit alongside Outreach, Salesloft, or Apollo, not replace them.
You're buying purely for raw contact volume. Dedicated data vendors like ZoomInfo and Apollo carry larger raw contact databases.
You want a free-forever tier. Salesmotion starts at $85/mo for individuals — there's no free plan.
Your motion is pure high-volume SMB outbound. The depth pays off most on considered, higher-ACV deals where understanding the account actually changes the conversation.

Ready to see a better way to sell?

Salesmotion replaces hours of manual research with real-time account intelligence your reps can use today.

Book a Demo See Product Tour

Product

See Salesmotion in Action

Salesmotion life sciences signal feed showing clinical trial, funding, and news signals across sponsor accounts — Real-time sponsor signals across your territory — the timing a consensus forecast can't give you.

Verified commercial contacts with email and phone, plus one-click AI outreach.

FAQ

Frequently Asked Questions

What is the best Evaluate alternative?

It depends on the job. For a different angle on forecasting and R&D research, Clarivate, GlobalData, and IQVIA are the strongest alternatives, and sister-brand Citeline leads on pipeline and trial data. For the commercial motion of selling into sponsors — which Evaluate isn't built for — Salesmotion is the best fit, adding sponsor discovery, real-time signals, verified contacts, and AI outreach.

Does Evaluate provide contact data or outreach?

No. Evaluate is a forecasting and commercial-intelligence platform — it has no decision-maker contacts, no sales-engagement or AI outreach features, and no documented CRM integration. If you need to reach and engage commercial buyers, that is a different category of tool, which is where Salesmotion fits.

Can Salesmotion replace Evaluate?

Not for forecasting. Evaluate is the industry standard for consensus forecasts and valuation, and Salesmotion does not replicate that. The tools serve different jobs — Evaluate informs strategy and finance, while Salesmotion drives the commercial selling motion. Teams that use both get the best of each.

Is Evaluate the same company as Citeline?

They are sister brands. Both Evaluate (forecasting) and Citeline (pipeline and trials) are part of Norstella, the roughly $5 billion life-sciences intelligence group formed through the 2021–2022 mergers that also include MMIT, Panalgo, and The Dedham Group. Neither is built for commercial prospecting and outreach.

How much do Evaluate alternatives cost?

The research and analytics platforms (Clarivate, Citeline, GlobalData, IQVIA) are all custom, enterprise-priced with no public pricing — generally five to six figures annually, with IQVIA typically the most expensive. Salesmotion is the outlier: flexible monthly pricing from $85/month for individuals, with custom team and enterprise pricing (unlimited users) and no annual lock-in.

Related Comparisons

Explore more head-to-head comparisons and alternatives guides.

Evaluate vs Salesmotion Citeline Alternatives Clarivate vs Salesmotion GlobalData Alternatives

Give every rep three AI agents to build more pipeline.

A Signal Agent, Research Agent, and Outreach Agent — working 24/7 so your team spends less time researching and more time closing.

Book a demo Or try the interactive demo